IPO - Quantum-Si Inc

Form Type: 424B5

Filing Date: 2025-01-06

Corporate Action: Ipo

Type: New

Accession Number: 000114036125000294

Filing Summary: Quantum-Si Inc. is offering 15,625,000 shares of its Class A common stock at a price of $3.20 per share to institutional investors. The offering is part of a registered direct offering pursuant to the company's prospectus supplement dated January 3, 2025, and the accompanying prospectus dated August 22, 2023. As of January 2, 2025, the last reported sale price of the common stock was $4.26 per share. The proceeds from this offering, estimated at $47 million after placement agent fees, are intended for future product development, general commercialization, research and development, and other corporate purposes. The firm has engaged A.G.P./Alliance Global Partners as the sole placement agent for this transaction. This move positions Quantum-Si to continue its mission of advancing protein sequencing technology and addressing challenges in the proteomics market. Quantum-Si is considered a controlled company, with Dr. Jonathan M. Rothberg beneficially owning over 50% of the voting power of its capital stock. This offering comes amid significant risks including market fluctuations and the ongoing development in the complex landscape of life sciences. Delivery of the securities is expected around January 6, 2025, contingent upon the fulfillment of certain closing conditions.

Document Link: View Document